foxo4-dri peptide senolytic human trial skin FOXO4-DRI: Status, Cancer Research & Data FOXO4-DRI: A Breakthrough Peptide Targeting – The disordered p53 transactivation domain
Pay in 4 interest-free payments of $6.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1





























